{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:01:51Z","timestamp":1784595711475,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1208\/s12249-018-1179-9","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T16:07:18Z","timestamp":1537200438000},"page":"3723-3733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of Nasal Inlet Ports Having Simplified Geometry for the Pharmacopeial Assessment of Mass Fraction of Dose Likely to Penetrate Beyond the Nasopharynx: a Preliminary Investigation"],"prefix":"10.1208","volume":"19","author":[{"given":"Gerallt","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Blatchford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyon P.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"issue":"11","key":"1179_CR1","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1007\/s11095-012-0804-7","volume":"29","author":"WH Doub","year":"2012","unstructured":"Doub WH, Adams WP, Wokovich AM, Black JC, Shen M, Buhse LF. Measurement of drug in small particles from aqueous nasal sprays by Andersen Cascade Impactor. Pharm Res. 2012;29(11):3122\u201330.","journal-title":"Pharm Res"},{"issue":"4","key":"1179_CR2","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/cphy.c100085","volume":"3","author":"A Tsuda","year":"2013","unstructured":"Tsuda A, Henry FS, Butler JP. Particle transport and deposition: basic physics of particle kinetics. Compr Physiol. 2013;3(4):1437\u201371.","journal-title":"Compr Physiol"},{"issue":"1","key":"1179_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1208\/s12249-011-9594-1","volume":"12","author":"X Liu","year":"2011","unstructured":"Liu X, Doub WH, Guo C. Assessment of the influence factors on nasal spray droplet velocity using phase-Doppler anemometry (PDA). AAPS PharmSciTech. 2011;12(1):337\u201343.","journal-title":"AAPS PharmSciTech"},{"key":"1179_CR4","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, June 1999, Draft Guidance for Industry, Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action. (Superseded by April 2003 Draft Guidance with same name.) [cited 6\/20\/2011]. Available from: \nhttp:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm070111.pdf\n\n."},{"key":"1179_CR5","unstructured":"US Pharmacopeial Convention: United States Pharmacopeia 41\/ National Formulary 36, Chapter <601> Aerosols, nasal sprays, metered-dose inhalers, and dry powder inhalers. Rockville, MD, 2018."},{"key":"1179_CR6","unstructured":"European Directorate for Quality in Medicines (EDQM): European pharmacopeia 9.0, monograph 0676. Nasal Preparations, Strasburg, France. EDQM 2017 (January)."},{"key":"1179_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/pharmaceutics6020195","volume":"6","author":"S Trows","year":"2014","unstructured":"Trows S, Wuchner K, Spycher R, Steckel H. Analytical challenges and regulatory requirements for nasal drug products in Europe and the U.S. Pharmaceutics. 2014;6:195\u2013219.","journal-title":"Pharmaceutics"},{"issue":"4","key":"1179_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1089\/jam.2006.19.409","volume":"19","author":"JP Mitchell","year":"2006","unstructured":"Mitchell JP, Nagel MW, Nichols SC, Nerbrink O. Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers. J Aerosol Med. 2006;19(4):409\u201333.","journal-title":"J Aerosol Med."},{"key":"1179_CR9","unstructured":"European Medicines Agency (EMEA). Guideline on the pharmaceutical quality of inhalation and nasal products. 2006; EMEA\/CHMP\/QWP\/49313\/2005 Final. London, UK. \nhttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003568.pdf\n\n. accessed August 9 2017."},{"key":"1179_CR10","unstructured":"Canada H. Guideline on the pharmaceutical quality of inhalation and nasal products. Health products and food branch. In: File 06-106624-547. Ottawa, Canada; 2005."},{"key":"1179_CR11","volume-title":"Aerosol technology: properties, behavior and measurement of airborne particles","author":"WC Hinds","year":"1999","unstructured":"Hinds WC. Aerosol technology: properties, behavior and measurement of airborne particles. 2nd ed. New York, USA: John Wiley & Sons Ltd.; 1999.","edition":"2"},{"issue":"4","key":"1179_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/089426803772455622","volume":"16","author":"JP Mitchell","year":"2003","unstructured":"Mitchell JP, Nagel MW. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations. J Aerosol Med. 2003;16(4):341\u201377.","journal-title":"J Aerosol Med."},{"key":"1179_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.2042-7158.1995.tb05747.x","volume":"47","author":"SP Newman","year":"1995","unstructured":"Newman SP, Steed KP, Hooper G, Brickwell J. Scintigraphic assessment of the oropharyngeal and nasal depositions of fusafungine from a pressurized inhaler and from a novel pump spray device. J Pharm Pharmacol. 1995;47:818\u201321.","journal-title":"J Pharm Pharmacol"},{"key":"1179_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/jps.2600730122","volume":"73","author":"CD Yu","year":"1984","unstructured":"Yu CD, Jones RE, Henesian M. Cascade impactor method for the droplet size characterization of a metered-dose nasal spray. J Pharm Sci. 1984;73:344\u20138.","journal-title":"J Pharm Sci"},{"key":"1179_CR15","first-page":"173","volume":"12","author":"Task Group on Lung Dynamics","year":"1966","unstructured":"Task Group on Lung Dynamics. Deposition and retention models for internal dosimetry of the human respiratory tract. Health Phys. 1966;12:173\u2013207.","journal-title":"Health Phys"},{"issue":"11","key":"1179_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/027868290883360","volume":"38","author":"JT Kelly","year":"2004","unstructured":"Kelly JT, Asgharian B, Kimbell JS, Wong BA. Particle deposition in human nasal airway replicas manufactured by different methods. Part I: inertial regime particles. Aerosol Sci Technol. 2004;38(11):1063\u201371.","journal-title":"Aerosol Sci Technol"},{"issue":"8","key":"1179_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/02786820300906","volume":"37","author":"YS Cheng","year":"2003","unstructured":"Cheng YS. Aerosol deposition in the extrathoracic region. Aerosol Sci Technol. 2003;37(8):659\u201371.","journal-title":"Aerosol Sci Technol"},{"issue":"3","key":"1179_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/jps.2600730314","volume":"73","author":"CD Yu","year":"1984","unstructured":"Yu CD, Jones RE, Henesian M. Cascade impactor method for the droplet size characterization of a metered-dose nasal spray. J Pharm Sci. 1984;73(3):344\u20138.","journal-title":"J Pharm Sci"},{"key":"1179_CR19","unstructured":"Doub WH, Adams WP. Measurement of drug in small particles\/droplets from aqueous nasal spray by cascade impaction. Poster session T3415 presented at Annual Meeting of the American Association of Pharmaceutical Scientists; Nov. 12, 2002. Toronto, Ontario."},{"key":"1179_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/jam.1998.11.Suppl_1.S-133","volume":"11","author":"SC Nichols","year":"1998","unstructured":"Nichols SC, Brown DR, Smurthwaite M. New concept for the variable flow rate Andersen cascade impactor and calibration data. J Aerosol Med. 1998;11:133\u20138.","journal-title":"J Aerosol Med"},{"issue":"1","key":"1179_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S1808-8694(15)31119-8","volume":"73","author":"IEK Trinidade","year":"2007","unstructured":"Trinidade IEK, Oliviera A, Gomes C, Sampaio-Texiera ACM, Trinidade HK. Adult nasal volumes assessed by acoustic rhinometry. Braz J Otorhinolaringol. 2007;73(1):32\u20139.","journal-title":"Braz J Otorhinolaringol"},{"key":"1179_CR22","unstructured":"Inhalanda Working Party of the European Pharmacopeia. Private communication. 2010."},{"issue":"3","key":"1179_CR23","first-page":"561","volume":"9","author":"JM Aiache","year":"1997","unstructured":"Aiache JM, Beyssac E. Modification of the Twin Impinger for the measurement of particle size from nasal sprays. Pharmeuropa. 1997;9(3):561\u20135.","journal-title":"Pharmeuropa"},{"key":"1179_CR24","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.2042-7158.1987.tb03142.x","volume":"39","author":"GW Hallworth","year":"1987","unstructured":"Hallworth GW, Westmoreland DG. The Twin Impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers. J Pharm Pharmacol. 1987;39:966\u201372.","journal-title":"J Pharm Pharmacol"},{"key":"1179_CR25","unstructured":"Williams G, Bickmann D, Blatchford C, Doub B, Mitchell J, Nichols S, Schiewe J, Suman J, Weda M. Towards standardizing methodology for quantifying the emitted fine mass fraction of active pharmaceutical ingredient (API) from nasal products (NPs). Drug delivery to the lungs-24. The Aerosol Society, Edinburgh, UK. 2013, pp. 89\u201392."},{"key":"1179_CR26","doi-asserted-by":"crossref","unstructured":"Marple VA, Roberts DL, Romay FJ, Miller NC, Truman KG, Van Oort M, Olsson B, Holroyd MJ, Mitchell JP, Hochrainer D. Next generation pharmaceutical impactor. Part 1: design. J Aerosol Med 2003;16(3):283\u2013299.","DOI":"10.1089\/089426803769017659"},{"issue":"4","key":"1179_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/jam.2004.17.335","volume":"17","author":"VA Marple","year":"2004","unstructured":"Marple VA, Olson BA, Santhanakrishnan K, Mitchell JP, Murray SC, Hudson-Curtis BL. Next generation pharmaceutical impactor: a new impactor for pharmaceutical inhaler testing. Part III. Extension of archival calibration to 15 L\/min. J. Aerosol Med. 2004;17(4):335\u201343.","journal-title":"J. Aerosol Med."},{"issue":"3","key":"1179_CR28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/089426803769017668","volume":"16","author":"VA Marple","year":"2003","unstructured":"Marple VA, Olson BA, Santhanakrishnan K, Mitchell JP, Murray SC, Hudson-Curtis BL. Next generation pharmaceutical impactor. Part II. Archival calibration. J. Aerosol Med. 2003;16(3):301\u201324.","journal-title":"Aerosol Med"},{"issue":"1 Pt 1","key":"1179_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/00005537-199801000-00023","volume":"108","author":"JA Schwab","year":"1998","unstructured":"Schwab JA, Zenkel M. Filtration of particulates in the human nose. Laryngoscope. 1998;108(1 Pt 1):120\u20134.","journal-title":"Laryngoscope"},{"key":"1179_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","volume":"3","author":"P Djupesland","year":"2013","unstructured":"Djupesland P. Nasal drug delivery devices: characteristics and performance in a clinical perspective\u2014a review. Drug Deliv Transl Res. 2013;3:42\u201362.","journal-title":"Drug Deliv Transl Res"},{"key":"1179_CR31","first-page":"213","volume-title":"Improving nasal drug delivery with HFA nasal aerosols","author":"H Derbyshire","year":"2013","unstructured":"Derbyshire H, Patel N, Wheeler A. Improving nasal drug delivery with HFA nasal aerosols. The Aerosol Society, Edinburgh, UK: Drug Delivery to the Lungs; 2013. p. 213\u20136."},{"key":"1179_CR32","unstructured":"Intertek S o p. AM560\/01. Melbourn, UK; 2018."},{"key":"1179_CR33","unstructured":"Pharma A, procedure S o. MO42\/01. Le Vaudreuil, France; 2018."},{"issue":"9","key":"1179_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/02786826.2014.931566","volume":"48","author":"Y Pu","year":"2014","unstructured":"Pu Y, Goodey A, Fang X, Jacob K. A comparison of the deposition patterns of different nasal spray formulations using a nasal cast. Aerosol Sci Technol. 2014;48(9):930\u20138.","journal-title":"Aerosol Sci Technol"},{"key":"1179_CR35","unstructured":"Kippax P. Malvern Panalytical Ltd., Malvern, UK. Private communication. 2018."},{"issue":"2","key":"1179_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1208\/s12249-008-9045-9","volume":"9","author":"M Bonam","year":"2008","unstructured":"Bonam M, Christopher D, Cipolla D, Donovan B, Goodwin D, Holmes S, et al. Minimizing variability of cascade impaction measurements in inhalers and nebulizers. AAPS PharmSciTechnol. 2008;9(2):404\u201313.","journal-title":"AAPS PharmSciTechnol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-018-1179-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-018-1179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T09:07:51Z","timestamp":1573463271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-018-1179-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1208\/s12249-018-1179-9","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}